Ticker Details
Tandem Diabetes Care, Inc. Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application.
IPO Date:	December 1, 2013
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$1.55B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.03 | 3.11%
Avg Daily Range (30 D):	$0.72 | 3.87%
Avg Daily Range (90 D):	$0.73 | 4.10%

Institutional Daily Volume
Avg Daily Volume:	1M
Avg Daily Volume (30 D):	1.79M
Avg Daily Volume (90 D):	1.96M

Trade Size
Avg Trade Size (Sh.):	85
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	76

Institutional Trades
Total Institutional Trades:	7,501
Avg Institutional Trade:	$2.72M
Avg Institutional Trade (30 D):	$1.89M
Avg Institutional Trade (90 D):	$2.06M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$4.86M
Avg Closing Trade (30 D):	$4.24M
Avg Closing Trade (90 D):	$4.55M
Avg Closing Volume:	118.06K

News

Apr 24, 2026 @ 6:18 PM FDA Flags High-Risk Recall For Tandem Diabetes Mob... Source: Vandana Singh

Mar 27, 2026 @ 1:00 PM Tandem Diabetes Care, Inc. Investigated by the Por... Source: Portnoy Law Firm

Mar 9, 2026 @ 10:30 PM [Latest] Global Intravenous Infusion Pump Market S... Source: Custom Market Insights

Feb 20, 2026 @ 6:01 PM Tandem Diabetes Shares Rise 33% On Earnings Beat, ... Source: Vandana Singh

Feb 8, 2026 @ 5:23 PM TNDM Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.92	$-.31	$-.3
Diluted EPS	$-.92	$-.31	$-.3
Revenue	$1.04B	$254.56M	$247.22M
Gross Profit	$583.32M	$144.78M	$136.79M
Net Income / Loss	$-63.32M	$-21.17M	$-20.39M
Operating Income / Loss	$-45.8M	$-13.79M	$-17.43M
Cost of Revenue	$458.1M	$109.78M	$110.43M
Net Cash Flow	$-1.29M	$-116.51M	$88.69M
PE Ratio

Splits
Oct 10, 2017	1:10